| ABO |
P16442
|
ABO, alpha 1-3-N-acetylgalactosaminyltransferase and alpha 1-3-galactosyltransferase
|
Enzyme
|
|
0.427 |
0.885 |
| PVT1 |
|
Pvt1 oncogene
|
|
|
0.495 |
0.731 |
| CASC15 |
|
cancer susceptibility 15
|
|
|
0.603 |
0.577 |
| MIR4435-2HG |
|
MIR4435-2 host gene
|
|
|
0.604 |
0.692 |
| NPHP3-ACAD11 |
|
NPHP3-ACAD11 readthrough (NMD candidate)
|
|
|
0.663 |
0.577 |
| CCDC26 |
Q8TAB7
|
CCDC26 long non-coding RNA
|
|
|
0.647 |
0.615 |
| LINC-PINT |
|
long intergenic non-protein coding RNA, p53 induced transcript
|
|
|
0.663 |
0.577 |
| RTEL1-TNFRSF6B |
|
RTEL1-TNFRSF6B readthrough (NMD candidate)
|
|
|
0.682 |
0.385 |
| LINC01122 |
|
long intergenic non-protein coding RNA 1122
|
|
|
0.821 |
0.269 |
| CMAHP |
Q9Y471
|
cytidine monophospho-N-acetylneuraminic acid hydroxylase, pseudogene
|
|
|
0.805 |
0.346 |
| MEF2C-AS1 |
|
MEF2C antisense RNA 1
|
|
|
0.861 |
0.154 |
| TSPOAP1-AS1 |
|
TSPOAP1, SUPT4H1 and RNF43 antisense RNA 1
|
|
|
0.792 |
0.346 |
| CCDC162P |
|
coiled-coil domain containing 162, pseudogene
|
|
|
0.890 |
0.154 |
| LINC00271 |
P0C7V0
|
long intergenic non-protein coding RNA 271
|
|
|
0.769 |
0.192 |
| INHCAP |
|
inhibitor of carbonic anhydrase pseudogene
|
|
|
0.890 |
0.231 |
| LINC01478 |
|
long intergenic non-protein coding RNA 1478
|
|
|
1.000 |
0.077 |
| ZMIZ1-AS1 |
|
ZMIZ1 antisense RNA 1
|
|
|
0.780 |
0.115 |
| SOCAR |
|
serous ovarian cancer associated RNA
|
|
|
0.821 |
0.231 |
| ZSCAN16-AS1 |
|
ZSCAN16 antisense RNA 1
|
|
|
0.792 |
0.269 |
| LINC01475 |
|
long intergenic non-protein coding RNA 1475
|
|
|
0.780 |
0.077 |
| STARD4-AS1 |
|
STARD4 antisense RNA 1
|
|
|
0.890 |
0.115 |
| LINC01091 |
|
long intergenic non-protein coding RNA 1091
|
|
|
0.821 |
0.231 |
| GMDS-DT |
|
GMDS divergent transcript
|
|
|
0.861 |
0.077 |
| MYOCOS |
A0A1B0GUC4
|
myocilin opposite strand
|
|
|
0.805 |
0.192 |
| SUZ12P1 |
|
SUZ12 pseudogene 1
|
|
|
0.890 |
0.115 |